P21-activated kinase 1 (Pak1) signaling influences therapeutic outcome in pancreatic cancer
Sankar Jagadeeshan(Ben-Gurion University of the Negev), Suresh K. Rayala(Indian Institute of Technology Madras), Swarnalatha Beesetti(Indian Institute of Technology Madras), Shilpa Tentu(Indian Institute of Technology Madras), Swathikan Chidambaram(Imperial College London), Jayadev Mavuluri(St. Jude Children's Research Hospital), Ganesh Venkatraman(Sri Ramachandra Institute of Higher Education and Research), Rohan Prasad Surabhi, Swetha Raghavan(Intel (India)), Hemdev Bhoopalan, S. Asha Nair(Rajiv Gandhi Centre for Biotechnology), Mahak Singhal(German Cancer Research Center), Soumya Sundaram(Sri Ramachandra Institute of Higher Education and Research), R. Malathi(University of Madras), Anirudh Subramanian(Indian Institute of Technology Madras), Ravi Shankar Pitani, Jayashree Biswal(Alagappa University)
Cited by 53
Related Papers
Determinants of burnout and other aspects of psychological well-being in healthcare workers during the Covid-19 pandemic: A multinational cross-sectional study
|PLoS ONE|2021|458
TAK1 restricts spontaneous NLRP3 activation and cell death to control myeloid proliferation
|The Journal of Experimental Medicine|2018|255